Skip to main content

What the FDA labels say about taking them together

Fentanyl and isradipine

Isradipine's FDA label of November 30, 2023 names fentanyl in its drug interactions section; the fentanyl labels PlainMeds reads (2) do not name isradipine. The isradipine label: “Fentanyl Anesthesia: Severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker.”

Check it at the source: the fentanyl FDA label on DailyMed (effective March 6, 2026, Hikma Pharmaceuticals USA Inc.); the isradipine FDA label on DailyMed (effective November 30, 2023, Teva Pharmaceuticals USA, Inc.).

What does the fentanyl label say about isradipine?

Fentanyl's label (effective March 6, 2026) and its 1 other brand-application label do not name isradipine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fentanyl Citrate), Hikma Pharmaceuticals USA Inc., effective March 6, 2026 (SPL set ce5db1c2-feb1-4ad2-847a-d02e865bd47e), via openFDA; the full label on DailyMed

What does the isradipine label say about fentanyl?

Isradipine label, drug interactions

Fentanyl Anesthesia: Severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker.

Source: FDA drug label (Isradipine), Teva Pharmaceuticals USA, Inc., effective November 30, 2023 (SPL set bf3425e0-428d-4bdb-ac9a-3b9d483df83a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Fentanyl generic labelers
3Isradipine generic labelers
FentanylIsradipine
Labeled forPainHigh blood pressure
Boxed warningYesNo
Pharmacy cost (NADAC)$1.79 per mL 100 mcg/2 mL vial$1.70 per capsule 5 mg capsule
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?